You're really nothing but a mean-spirited fool and most recognize that. No one will listen to your ramblings because they are not based in science and/or finance. You have my pity and I wish you a good day.
The Trout Group does in fact represent many companies in the Life Science's arena. If those that have called you a liar had done their research they would know that. In fact, if you go to The Trout Group's homepage you will see a picture of Tricia Trueheart and a list of all the companies The Trout Group represents, including Achillion.
I find it amusing that Cramer is now saying how the Abbvie/Express Script deal has apparently not presented a new paradigm is drug pricing. He should read what his minions write. Adam Feurstein said exactly the opposite only a few short days ago and Cramer, at that time, agreed with him. I would take what Adam writes with a grain of salt. His claim to fame as a biotech expert comes from the reality that he was a realtor in San Francisco. He is often wrong but even a stopped clock is right twice a day.
I understand why insiders often sell shares. They may want to diversify their investments, build a new home, or send their kid to Harvard. Sometimes they sell their company shares because they know there are problems ahead. But I can only think of one reason insiders would buy shares in their company. They must believe that their company is undervalued for some reason or another. It seems to me the faith insiders show in SGEN by buying so many shares is bullish. Perhaps there is a reason I haven't considered and would appreciate any illumination.
It's always about the money. Express Scripts is about the money. Gilead is about the money. It's always about the money. Having wrote that, Gilead is not a one trick pony. They have some promising drugs in their oncology pipeline and they have a certificate they recently bought that gives them the right to exercise a priority review from the FDA. I would like to see Gilead buy ACHN which reported positive results on a potential 4 week treatment for HVC. Their protease inhibitor is combined with Sovaldi and showed 100% effectiveness in 6 weeks of treatment. I also think that if Gilead can afford to sell Harvoni in France for $56000 for a 12 week regimen they can afford to lower their price here in the United States. All of these companies are using the basic research conducted by our government in these protease inhibitors from many years ago. I know people vote with their pocketbooks and companies conduct business based on their pocketbooks. There needs to be a compromise.
The company wouldn't bring this talent on and the talent wouldn't come on unless they felt the technology works.
Your concern for those long Inovio is truly heartwarming. It's nice to have good people like you looking out for others.
Because they are truly concerned about the long's well being. Shorts are caring people with a positive outlook on life and hearts full of love and caring.
There are some rude and some civil on this board. I only read certain post that appear to be from individuals that have done their research. As far a those that simply post an opinion, everyone has a right to their own opinion but they don't have a right to their own facts. Of course Gilead will face competition. Of course Gilead will have failures. But Gilead is not a one trick pony. Leader in HIV. Leader in Hep C. Strong pipeline in oncology. Very, very strong balance sheet. Looks like a strong buy to me but that's just my opinion.
Sentiment: Strong Buy
Your concern for those long on Inovio is truly touching. Why do care so much about helping us poor ignorant investors? Thank you so very much for your thoughtful insight.
This law firm has sued just about every company on this planet. Dreamworks, Foster Wheeler, Carl Icahn, Zillow, Northwest Bio, Arden Group, STAAR Surgical, CenturyLink, etc. etc. Anyone can sue anybody at anytime for any reason. Release gave absolutely no details. They file against a company and distract them from doing what they do while knowing that eventually the company will say it's cheaper to settle than to fight. Ambulance chasers are everywhere. If the suit has merit then why not explain it?
Read the May 14, 2013 news release by Inovio regarding preclinical study of Ebola and Marburg viruses. Either you know that the information you are releasing is false and you don't care or you don't know your information is false because you have done almost zero research. Either way, you are one post everyone should avoid.
AF has a bachelor's degree in political science from Emory and sold real estate in San Francisco. How much more expertise can one hope for?
AF's analysis of Inovio reminds me more of someone reading Taro Cards and tea leaves. His latest article basically accuses Inovio of hiding data from 5 patients and thus skewing the results. He seems to fail to understand that the results of this Phase 2 will be peer reviewed. AF is certainly not a peer. He was a real estate agent in San Fran before deciding to become whatever he is now. I welcome cogent arguments against Inovio and their science but AF has an agenda. He truly seems to dislike Dr. Kim and Inovio. Why? I don't have a clue but he is far from being objective. BTW, if you had listened to AF regarding Gilead a few years ago you would have missed a dang good run. I didn't listen to him then and won't now. Even a blind squirrel finds a nut every once in a while, so AF may be correct in his analysis. But if he is it will be pure luck and nothing else.